|
Reference | Participants | Treatment | Treated muscles | Outcome measures | Placebo | Other treatments | Results | Side effects |
|
Lohse-Busch et al. 1997 [14] | 35 children and young adults with CP | FSWT: 1 session; 0.06 mJ/mm2; 500 shots for each treated muscle | Hamstrings, Triceps surae and Ileopsoas | ROM | No | Physiotherapy | ↑ ROM lasting ≥3 weeks | No |
|
Amelio and Manganotti, 2010 [13] | 12 children with CP | FSWT: 1 session; 0.03 mJ/mm2; 4500 shots in total | Triceps surae | ROM, MAS, baropodometry | 1 session of placebo followed 6 weeks later by FSWT | No | ↑ ROM, ↓ MAS scores, and ↑ plantar surface area lasting ≥4 weeks and <12 weeks after FSWT. No effects after placebo | No |
|
Vidal et al. 2011 [24] | 15 children and adults with CP | RSWT: 3 sessions (1/week); 2 Bars; in each session, 2000 shots for each treated muscle | Forearm and wrist flexors; hip adductors; soleus and hamstrings | AS for upper limb muscles; ROM for lower limb muscles | Placebo was applied to 13 muscles (patients’ number not specified) | Not specified | ↓ AS scores and ↑ ROM lasting ≥8 weeks and <12 weeks after FSWT. No effects after placebo | Petechiae and light pain during RSWT in 3 patients |
|
Gonkova et al. 2013 [22] | 25 children with CP | RSWT: 1 session; 1.5 Bars; 4500 shots in total | Triceps surae | ROM, MAS, and baropodometry | 1 placebo session, then RSWT after 1 month | No | ↓ MAS scores and ↑ ROM lasting ≥4 weeks after RSWT. No effects after placebo | No |
|
Manganotti and Amelio, 2005 [15] | 20 adults with poststroke spasticity | FSWT: 1 session; 0.03 mJ/mm2; 4700 shots in total | Wrist flexors; interosseus muscles of the hand | ROM, AS, MCV, and F-waves from ADM; EMG (FDI) | 1 placebo session followed by FSWT after 1 week | Not specified | ↑ ROM lasting 4–12 weeks after FSWT. ↓ AS scores lasting 4–12 weeks in wrist flexors and lasting ≥12 weeks in fingers flexors after FSWT. No changes of MCV, F-waves, and EMG after FSWT. No effects after placebo | No |
|
Troncati et al. 2013 [20] | 12 adults with poststroke spasticity | FSWT: 2 sessions (1 session per week); 0.08/0.105 mJ/mm2; 800/1600 shots for each treated muscle | Flexor muscles in the forearm; interosseus muscles of the hand | MAS, subscores of the upper limb FM scale for motricity, ROM and pain; perceived benefit (VAS) | No | Not specified | ↑ ROM and motricity subscores and ↓ MAS scores lasting ≥6 months. ↓ Pain lasting 1–12 weeks. No changes in perceived benefit (VAS) | No |
|
Santamato et al. 2013 [18] | 16 adults with poststroke spasticity | FSWT: 5 sessions (1 session every day starting from BoNT-A injection); 0.03 mJ/mm2; 2000 shots in total | Flexor digitorum superficialis muscle | MAS; VAS for pain and frequency of muscle spasms | No | BoNT-A | ↓ MAS scores and ↓ pain lasting 1–3 months. ↓ Frequency of muscle spasms lasting ≥3 months. In 16 patients treated with BoNT-A and electrical stimulation, the results were shorter in duration and smaller in size | No |
|
Moon et al. 2013 [16] | 30 adults with poststroke spasticity | FSWT: 3 sessions (1 session per week); 0.089 mJ/mm2; 1500 shots in total | Medial and lateral gastrocnemius | ROM, clonus score, FM assessment of the lower limb, MAS, biomechanical assessment (PET and TTA) | 1 placebo session followed by FSWT | Physiotherapy | ↓ MAS scores and PET values lasting 1–4 weeks. No effects after placebo | No |
|
Santamato et al. 2014 [17] | 23 adults with poststroke spasticity | FSWT: 1 session; 0.10 mJ/mm2; 4500 shots in total | Triceps surae | ROM, MAS, MCV, and F-waves from AH | No | No | ↓ MAS scores and ↑ ROM lasting ≥1 month after FSWT in the patients with baseline HS <4. No long-lasting effects in patients with HS = 4. No MCV and F-waves changes after FSWT | Pain in 5 subjects and local weakness in 2 subjects |
|
Kim et al. 2013 [23] | 57 adults with poststroke spasticity | RSWT: 5 sessions (1 session every 2 or 3 days); 1.6 Bars; in each session, 3000 shots in total | Subscapularis muscle | ROM, MAS, VAS for pain | No | Physiotherapy | ↓ MAS scores, ↓ pain, and ↑ ROM lasting 4 weeks | Petechiae in 1 patient and light pain during RSWT in some patients |
|
Trompetto et al. 2009 [21] | 3 adults with secondary dystonia and 3 with writer’s cramp | FSWT: 4 sessions (1 session per week); 0.03 mJ/mm2; up to 8000 shots | Forearm and hand muscles | UDRS, ADDS, 4-point pain intensity scale, median nerve SEPs, F-waves from ADM | 1 placebo session followed by FSWT after 2 weeks | No | In patients with secondary dystonia, clinical benefit on dystonia and pain lasting 1-2 months. Less consistent effects on writer’s cramp patients. No changes of SEPs and F-waves after FSWT. No effects after placebo | No |
|
Sohn et al. 2011 [19] | 10 adults with poststroke spasticity | FSWT: 1 session; 0.10 mJ/mm2; 1500 shots in total | Medial gastrocnemius muscle | MAS, F-waves from AH and H-reflex from soleus | No | No | ↓ MAS scores just after FSWT (no follow-up). No changes of F-waves and H-reflex | Mild pain during FSWT |
|
Manganotti, et al. 2012 [25] | 10 healthy subjects | FSWT: 1 session; 0.03 mJ/mm2; 1600 shots in total | Right ADM | MCV, F-waves, and MEPs from right ADM; SAP from 5° finger by ulnar nerve stimulation | No | No | No changes in any of the investigated parameters | No |
|